Champix (varenicline) - lots to be recalled due to presence of impurity N-nitroso-varenicline above the Pfizer acceptable daily intake limit

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Champix
Active substance
varenicline
Therapeutic area (MeSH)
Tobacco Use Cessation
Procedure number
EMEA/H/C/000699
DHPC type
Quality defect
Human ATC code
N07BA03
Dissemination date
15/07/2021

How useful was this page?

Add your rating